We presented the British guidelines for mrd monitoring. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Lekka, Dr Kostopoulou

Another study showing the superiority of adding in vivo T cell depletion  Biol Blood Marrow Transplant   . 2020 Oct;26(10):1868-1875.  doi: 10.1016/j.bbmt.2020.06.030.Epub 2020 Jul 5. Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG Jad Othman 1, Matthew Greenwood 2, John Moore 3, Stephen Larsen 4, Anne-Marie Watson 5, Chris Arthur 6, Abir Bhattacharyya 7, Ian Bilmon 7, Emily Blyth 7, Adam...

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Lekka, Dr Kostopoulou

A retrospective study compared our regimen of ptcy d3 and d5 with csa/MMf start at day 0/1 with other combinations and in MV analysis showed better performance. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Lekka, Dr Kostopoulou Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study...

Μετά την έλευση 2 χρόνων από το προηγούμενο σεμινάριο, σας προσκαλούμε με μεγάλη μας χαρά στο 2o Εκπαιδευτικό Σεμινάριο στην Μεταμόσχευση Μυελού των Οστών. Την πρώτη μέρα του σεμιναρίου θα ανασκοπηθούν καινούρια δεδομένα στην μεταμόσχευση μυελού και θα δοθεί έμφαση στις επιπλοκές των καινούριων κυτταρικών θεραπειών, τόσο επίκαιρες σήμερα, όπως το...

We discussed and we adapted the following protocol BBMT 2018 Stem cell mobilization was achieved using granulocyte colony-stimulating  factor (G-CSF) at 10 to16 μg/kg/day for 3 to 4 days after dialysis on  dialysis days Melphalan was dosed at 70 to 200 mg/m2 divided over2 days (days -3 and  -2...

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Kostopoulou

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Kostopoulou

Best Abstract award in EBMT 2020, Madrid O066 - FLAMSA-BASED REDUCED INTENSITY CONDITIONING VERSUS MYELOABLATIVE CONDITIONING IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH ACTIVE DISEASE AT THE TIME OF TRANSPLANTATION: AN ALWP/EBMT ANALYSIS Eduardo Rodríguez-Arbolí1, Myriam Labopin2, Johanna Tischer3, Arne Brecht4, Arnold Ganser5, Jürgen Finke6, Igor Wolfgang Blau7,...

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

A retrospective analysis of PTCY vs ATG performed form ALWP of EBMT and contribution of our team. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas

Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Lekka, Dr Vadratsikas